Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serine palmitoyltransferase assembles at ER-mitochondria contact sites. | Life Sci Alliance | 2022 | 34785538 | PubTator, text mining | PubMed |
| Antimicrobial resistance in the globalized food chain: a One Health perspective applied to the poultry industry. | Braz J Microbiol | 2022 | 34775576 | PubTator, text mining | PubMed |
| Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology. | Life Sci Alliance | 2022 | 34764206 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis. | Bone | 2022 | 34743040 | PubTator, text mining | PubMed |
| The potential and limitations of intrahepatic cholangiocyte organoids to study inborn errors of metabolism. | J Inherit Metab Dis | 2022 | 34671987 | PubTator, text mining | PubMed |
| Compartmentalization of Sphingolipid metabolism: Implications for signaling and therapy. | Pharmacol Ther | 2022 | 34582834 | PubTator, text mining | PubMed |
| Regional personality assessment through social media language. | J Pers | 2022 | 34536229 | PubTator, text mining | PubMed |
| Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration. | Curr Neuropharmacol | 2022 | 34414870 | PubTator, text mining | PubMed |
| The Possible Mechanism of Physiological Adaptation to the Low-Se Diet and Its Health Risk in the Traditional Endemic Areas of Keshan Diseases. | Biol Trace Elem Res | 2022 | 34365573 | PubTator, text mining | PubMed |
| Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report. | Am J Kidney Dis | 2022 | 34245816 | PubTator, text mining | PubMed |
| Posttransplant recurrence of calcium oxalate crystals in patients with primary hyperoxaluria: Incidence, risk factors, and effect on renal allograft function. | Am J Transplant | 2022 | 34174139 | PubTator, text mining | PubMed |
| Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria. | Br J Clin Pharmacol | 2022 | 34022071 | PubTator, text mining | PubMed |
| Creativity comes from interactions: modules of protein interactions in plants. | FEBS J | 2022 | 33774929 | PubTator, text mining | PubMed |
| Sphingolipids in embryonic development, cell cycle regulation, and stemness - Implications for polyploidy in tumors. | Semin Cancer Biol | 2022 | 33429049 | PubTator, text mining | PubMed |
| The metabolic importance of the overlooked asparaginase II pathway. | Anal Biochem | 2022 | 33347861 | PubTator, text mining | PubMed |
| Genetic Architecture of Childhood Kidney and Urological Diseases in China. | Phenomics | 2021 | 36939782 | PubTator, text mining | PubMed |
| Implications of Sphingolipids on Aging and Age-Related Diseases. | Front Aging | 2021 | 35822041 | PubTator, text mining | PubMed |
| Clinical Outcomes of Endovascular Treatment for Carotid Artery Dissection Without Intracranial Large Vessel Occlusion in Patients With Cerebral Ischemia Presentation. | Front Neurol | 2021 | 35185743 | PubTator, text mining | PubMed |
| Hyperoxaluria: An early diagnosis will allow a timely combined renal and liver transplantations to avoid irreversible damages to all other organs. | J Transl Int Med | 2021 | 35136730 | PubTator, text mining | PubMed |
| Role of Ceramides in the Molecular Pathogenesis and Potential Therapeutic Strategies of Cardiometabolic Diseases: What we Know so Far. | Front Cell Dev Biol | 2021 | 35127726 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=44